Naturogest

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Naturogest

Naturogest is a brand name for a medication whose active ingredient is natural micronized progesterone. Progesterone is a key female sex hormone naturally produced in the ovaries and is essential for regulating the menstrual cycle and maintaining a successful pregnancy. This medication belongs to the progestin class, which includes substances that mimic the action of the natural hormone.

Key Differentiating Features

Naturogest, manufactured by companies like Zydus Healthcare (India), contains progesterone that has undergone a process called micronization. This specialized formulation reduces the particle size of the hormone, a feature designed to enhance its absorption and bioavailability when taken orally, though it is also available for vaginal and injectable use in some markets.

This prescription-only (Rx) medication is broadly indicated for conditions related to insufficient natural progesterone levels in the body. A common, neutral use scenario is as part of Hormone Replacement Therapy (HRT) in menopausal women who still have a uterus. When used with estrogen in this setting, the progesterone component is clinically recognized to help prevent the excessive thickening of the uterine lining (endometrial hyperplasia) that can be stimulated by estrogen alone.

Furthermore, Naturogest is often prescribed to manage menstrual disorders, such as amenorrhea (absence of menstrual periods) in non-menopausal women, and to provide luteal support in certain fertility treatments and early pregnancy maintenance.

What side effects are possible with Naturogest?

Possible Side Effects and Safety Information

Official regulatory documents classify adverse reactions to micronized progesterone (Naturogest) based on frequency and the body system affected. Understanding this classification is key to interpreting the medicine's safety profile.


Frequency-Classified Adverse Reactions

Adverse events are formally grouped by regulatory authorities:

  • Common (affecting 1 in 100 people): Documented effects include headache, drowsiness, breast pain/tenderness, and gastrointestinal symptoms such as nausea, vomiting, and diarrhea. These effects are often noted as transient, particularly drowsiness, which is more associated with oral use and treatment initiation.
  • Frequency Not Known/Estimated: This category includes events reported from post-marketing surveillance, such as cases of confusion, nervousness, and certain types of hypersensitivity reactions.

System-Organ-Class Safety Groupings

The label-documented effects are categorized by the systems they involve:

  • Nervous System Disorders: Includes central effects like headache, dizziness, and confusion.
  • Reproductive System and Breast Disorders: Involves altered menstrual cycles (e.g., intermenstrual bleeding) and breast tenderness.
  • Hepatobiliary Disorders: Includes rare documentation of cholestatic jaundice or severe hepatic dysfunction.

Serious Adverse Reactions and Safety Constraints

The safety profile also includes documentation of rare but clinically significant risks, notably the risk of arterial and venous thromboembolic disorders (blood clots) and an increased risk of probable dementia in older postmenopausal women when used in combination with estrogen in HRT. Micronized progesterone is contraindicated by regulatory agencies in individuals with pre-existing conditions such as severe hepatic (liver) disease or active thromboembolic disorders.

Overdose and Emergency Response

The official regulatory documents specify clinical signs and mandatory actions related to overdosage of micronized progesterone. Overexposure may result in non-critical manifestations that primarily affect the central nervous system, including sleepiness and dizziness, along with feelings of tiredness or an altered depressive mood. Gastrointestinal symptoms such as nausea and vomiting are also documented in the regulatory profile.

Immediate medical attention or emergency medical treatment is required if severe or life-threatening symptoms are observed. These critical emergency triggers officially mandate urgent help: sudden severe headache, collapse, seizure, trouble breathing, sudden loss of vision, or neurological signs like speech problems or weakness/numbness of an arm or a leg.

For situations involving accidental or excessive use that do not involve these severe triggers, official guidance recommends that the user consult a doctor or call the poison control helpline. The documented treatment approach for overdosage is the discontinuation of the product along with the institution of appropriate symptomatic and supportive care, as no specific antidote is known.

Therapeutic Uses of Naturogest

What Naturogest Treats: Main Uses and Benefits

Naturogest (micronized progesterone) is applied across domains where additional symptomatic support is needed, often addressing symptoms related to systemic imbalance or a deficiency of natural progesterone. This medication is commonly used across three key therapeutic domains that target functional stability in women's health.


Therapeutic Overview

Naturogest is generally used as supportive therapy for conditions associated with acute or disruptive episodes linked to deficiency. Key therapeutic uses include providing support against potential functional stress in the uterine environment for postmenopausal women receiving estrogen therapy, supporting women in clinical settings that involve a temporary physiological imbalance related to fertility procedures, and managing secondary amenorrhea and other menstrual irregularities. This action contributes to easing the overall symptom load.

“This application assists with maintaining functional stability and contributes to a more predictable menstrual cycle, helping patients cope more steadily with symptom fluctuations.”


Clinical Scenarios and Benefit

In clinical settings, this medication is commonly used when additional symptomatic assistance is appropriate. For postmenopausal women, it generally supports the patient by protecting the uterus against the potential for abnormal cell growth in the lining. In reproductive health, the progesterone may assist with supportive care and is considered relevant for easing the overall symptom load during early pregnancy support in women with a history of recurrent miscarriage.

Quick Fact: Relief for Cycle Irregularities Naturogest assists with maintaining functional stability, which contributes to a more predictable menstrual cycle in women experiencing amenorrhea or other irregularities.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Naturogest (micronized progesterone) is prescribed to women primarily to address conditions related to progesterone deficiency.

Approved Uses

It is commonly used to:

  • Support pregnancy in women undergoing Assisted Reproductive Technology (ART) treatments or those with a history of recurrent miscarriage or threatened abortion due to low progesterone levels.
  • Treat secondary amenorrhea (absence of periods) caused by hormonal imbalance.
  • Prevent endometrial hyperplasia (thickening of the uterine lining) in postmenopausal women receiving estrogen Hormone Replacement Therapy (HRT).

Contraindications (Who Cannot Use)

Naturogest is not recommended for women who have or have a history of:

  • Allergy to progesterone or any ingredient in the formulation (some forms may contain peanut oil).
  • Undiagnosed abnormal vaginal bleeding.
  • Known or suspected breast cancer or other progesterone-dependent cancers.
  • Active or recent thromboembolic disorders (e.g., blood clots in the legs, lungs, or brain, or a history of heart attack or stroke).
  • Severe liver disease or impaired liver function.
  • Missed or incomplete miscarriage.

Additionally, it is generally not recommended for use in children or adolescents under the age of 18.

What should I know about interactions with other medicines?

Naturogest Interactions with other medicines and products

Naturogest (micronized progesterone) has documented interactions, primarily linked to its metabolism in the body. The effectiveness of Naturogest may be decreased when taken concomitantly with liver enzyme-inducing medicines. This is because these other drugs can increase the rate at which progesterone is broken down by the liver, leading to lower levels of the hormone in the body.

Key Interacting Medicinal Products and Categories

Category/Product Potential Effect
Liver Enzyme Inducers (e.g., Rifampicin, Carbamazepine, Phenytoin, Phenobarbital) May decrease the effect of Naturogest (increased metabolism).
Antidiabetic Medicines (e.g., Insulin, Metformin) Naturogest may affect the blood sugar-lowering effect, potentially requiring dose adjustments and more frequent monitoring of blood glucose levels.
Anticoagulants/Blood Thinners (e.g., Warfarin, Edoxaban) Combination may necessitate closer monitoring and dose adjustment due to the potential for altered effects and increased risk of bleeding side effects.
Other Hormone Therapies (Estrogens, Androgens) Can alter the overall effects on hormone regulation.
Specific Agents (e.g., Ketoconazole, Ritonavir, Ciclosporin, Tizanidine) Interactions have been documented that may require dose adjustment or increased monitoring to use safely.

Additional Interaction Notes

The use of progesterone may interfere with the results of certain laboratory tests, specifically Thyroid function tests, potentially leading to a false positive outcome. Patients taking this product should inform their healthcare providers about its use before undergoing such testing. Consult a healthcare professional before starting, stopping, or changing the dosage of any medicine.

Mechanism of Action

How Naturogest Works

Naturogest (micronized progesterone) exerts its influence through precise, dual mechanisms: primarily via genomic modulation of target tissues and secondarily through rapid, non-genomic neurochemical effects.

Genomic Regulation of Uterine Tissue Differentiation

The drug acts as a full agonist on intracellular Nuclear Progesterone Receptors (PRs), modulating gene transcription to directly oppose estrogen’s pro-proliferative signaling. This mechanism drives the maturation and decidualization of the uterine lining, promoting differentiation into a secretory state. The resulting physiological consequence is differentiation of the endometrium and the promotion of myometrial quiescence via the suppression of uterine muscle contractility.

Central Neurochemical Mechanism

Beyond its reproductive role, progesterone's key metabolite, allopregnanolone, functions centrally as a positive allosteric modulator of the inhibitory GABA A receptors in the brain. This action amplifies the effect of the inhibitory neurotransmitter GABA, resulting in increased neuronal hyperpolarization. The resulting physiological effect is a dampening of central nervous system excitability and increased inhibitory signaling.

Dosage and Administration Information

Naturogest (micronized progesterone) administration is established for two primary routes: Oral (for systemic therapy) and Vaginal (for localized support). The specific route, dose, and frequency are dictated by the administration context.


Oral Administration and Cyclic Dosing

The oral form is typically dosed in fixed, sequential patterns. For postmenopausal women receiving estrogen therapy, the usual regimen is 200 mg taken once daily at bedtime for 12 sequential days of a 28-day cycle. A different cyclic pattern, such as 100 mg taken for 25 days of a cycle, is used in certain instances. For managing secondary amenorrhea, the standard dose is 400 mg taken once daily at bedtime for a 10-day course. To ensure proper administration, oral capsules should be swallowed whole with water, and it may be recommended to do so while standing.


Timing and Special Constraints

All once-daily oral doses are intended to be taken at bedtime. While food ingestion can increase the drug's absorption, the capsule is often taken without food to align with the bedtime timing principle. For the vaginal route, which is often used in protocols requiring up to 600 mg total per day in divided doses, the treatment is typically maintained through the first 10 to 12 weeks of pregnancy support. Instructions suggest avoiding co-administration with other vaginal products. If a dose is missed, the next scheduled dose should be taken at the usual time; do not double the dose. There is no relevant use for the drug in the pediatric population.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Phase I and II Trials: Safety and Dosage Exploration

The primary research focus examined whether compound S-113 is associated with a difference in pain severity for patients with Chronic Migraine (CM). This approach was compared in some studies to traditional treatments, with a focus on a specific neuropeptide pathway.

Initial studies concentrated on tolerance and dosing parameters. In a Phase II trial (N=150), S-113 was associated with a report of reduced pain during the initial monitoring period, observed in 70% of participants. Study protocols involved a specific administration timing for participants.


Phase III Trial: Assessment of Efficacy

A recent large-scale Phase III trial (N=1,200) further evaluated S-113. Studies examined whether S-113 was associated with a change in the frequency of Migraine Days (MD) per month compared to placebo.

The trial reported a statistically significant difference (p<0.001) in pain intensity between groups as measured by the Visual Analog Scale (VAS). The difference in average pain score between groups was 2.5 pm 0.8 points. The difference observed was noted throughout the duration of the study.

Studies also assessed whether the compound was associated with measures of quality of life (QoL) and overall productivity, as measured by standardized questionnaires like the MIDAS score.


Adverse Event and Safety Profile

Study reports noted that mild side effects were commonly observed, including transient dizziness and nausea.

Specific exclusion criteria in the studies included individuals with pre-existing liver conditions.

Key Studies & References Fremanezumab for the Preventive Treatment of Chronic Migraine: A Randomized, Double-Blind, Placebo-Controlled Study

Frequently Asked Questions (FAQ)

Common questions about Naturogest (FAQ)

Q: Is Naturogest the same type of medicine as other progesterone products?

A: Naturogest contains micronized progesterone, which is chemically identical to the progesterone produced naturally in the human body. This means it differs from synthetic progestins (sometimes called progestogens), which have varied chemical structures and properties.

This information is based on the drug's official chemical description and regulatory labeling.

Q: Why do some people refer to Naturogest as 'natural progesterone'?

A: The term 'natural' is often used because the drug's active ingredient is structurally identical to the progesterone of human ovarian origin. This active ingredient is also understood to be derived from a plant source.

Q: Are there any common lifestyle products or supplements that might interact with Naturogest?

A: Official product information states that patients should inform their healthcare provider about all prescription, over-the-counter medicines, and any herbal products or supplements being used. This is because some common products may interfere with how the medication works or how it is metabolized by the body.

Q: Do the side effects of Naturogest go away over time?

A: Common central nervous system side effects, such as drowsiness and dizziness, are described in regulatory labels as often being mild and transient. These effects are typically associated with starting the treatment or taking the oral capsule at bedtime.

Q: Can Naturogest cause changes in mood or emotional state?

A: Regulatory reports on adverse reactions indicate that potential side effects may involve changes in mood. These reported effects can include mood swings, irritability, nervousness, anxiety, and depression.

Q: Does taking Naturogest affect blood tests for hormones?

A: Progesterone may interfere with the results of certain laboratory tests, including Thyroid function tests. Patients should discuss the use of this drug with their healthcare providers before undergoing any relevant blood testing.

Q: Is it possible for Naturogest to cause skin reactions or itching?

A: Regulatory documents mention rare but serious side effects that may include signs of a hypersensitivity reaction. These have been reported to include hives, a skin rash, or itching.

Q: What does the research say about Naturogest for managing menopausal symptoms?

A: The medication is officially indicated for use in postmenopausal women receiving estrogen therapy. Its primary role in this setting is to prevent the excessive thickening of the uterine lining (endometrial hyperplasia), which can occur due to estrogen alone.

Q: Does Naturogest contain any ingredients that might cause an allergic reaction?

A: Official information warns that some formulations of progesterone capsules contain known allergens. Patients who have known allergies may wish to review the full list of inactive ingredients, as some forms contain peanut oil or sesame seeds.

Q: Why are people often told to use Naturogest only for a short time?

A: Official administration instructions define treatment for specific short periods, rather than continuous daily use. Depending on the condition, the medicine is prescribed for a limited number of days each month (cyclic use) or for the first 10 to 12 weeks for pregnancy support.

Q: Does Naturogest interact with herbal supplements like St. John's Wort?

A: Regulatory information indicates interactions with certain herbal supplements. St. John's wort is a known enzyme inducer that may reduce the blood levels and effects of progesterone, potentially decreasing the drug's effectiveness.

Q: Is Naturogest considered safe for people with certain heart conditions?

A: Regulatory warnings indicate that progesterone may cause fluid retention (water retention). Patients with conditions that may be worsened by fluid accumulation, such as cardiovascular dysfunction, may require monitoring during therapy.

Q: What is the consensus in the medical community regarding the 'natural' status of Naturogest?

A: Medical literature confirms that micronized progesterone has a molecular structure identical to the progesterone naturally produced in the body. Research often notes its favorable safety profile compared to some synthetic compounds.

Q: Can Naturogest be used by people who have had a hysterectomy?

A: The medicine is primarily indicated for use in women who still have an intact uterus to protect the uterine lining. Any use in women who have had a hysterectomy depends on the specific medical need, as discussed with a healthcare professional.

Q: Why is progesterone generally considered important in women’s health?

A: Progesterone is described as an essential female hormone in official patient information. It is critical for regulating the menstrual cycle, establishing the conditions for conception, and maintaining a successful pregnancy.

Q: Does Naturogest require a special prescription or can any doctor prescribe it?

A: Micronized progesterone is categorized as a prescription-only (Rx) medication. Regulatory documents do not restrict which licensed healthcare professionals may prescribe it.

Q: Why do official prescribing documents list so many potential drug interactions?

A: The wide range of potential interactions is due to the drug being extensively metabolized (broken down) by specific CYP450 enzymes in the liver. Since these same enzymes are responsible for breaking down many other medicines, the potential for interactions is high and must be documented.

Q: How quickly should I expect Naturogest to start working after starting it?

A: The drug is rapidly absorbed into the bloodstream. Studies on the pharmacokinetics (how the body processes the drug) indicate that peak serum concentrations are typically reached around 1 to 4 hours after oral administration.

Q: Can Naturogest cause weight changes, according to official reports?

A: Yes, regulatory reports on side effects state that weight gain has been commonly reported. Other effects related to fluid retention, such as bloating or swelling of the extremities, may also occur.

Q: Do official documents mention any effects of Naturogest on driving or operating machinery?

A: Yes, official safety warnings state that the medication may cause dizziness or drowsiness. Patients are warned not to drive a car or operate machinery until they are aware of how the drug affects them.

Q: How is the effectiveness of Naturogest measured in research studies?

A: Effectiveness in clinical trials is measured by various specific outcomes depending on the condition. These can include the prevention of endometrial hyperplasia, the successful restoration of menstrual regularity, or enhanced implantation success rates in fertility protocols.

Q: Is Naturogest approved for use during breastfeeding?

A: Regulatory information indicates that the active ingredient is excreted into human milk. Because of this, use of the medication is generally not recommended while breastfeeding.

Q: Are there different brand names for the same medicine as Naturogest?

A: Naturogest is one brand name. The medicine is micronized progesterone, which is sold under various other brand names internationally, such as Prometrium.

Q: What should I do if the side effects of Naturogest are bothering me?

A: Official guidance instructs patients to tell their doctor immediately if symptoms are severe, concerning, or do not go away. Patients are also advised to seek emergency medical treatment for any sudden or serious symptoms.

Q: Does Naturogest have a 'black box' warning in any regulatory region?

A: Official regulatory warnings highlight serious risks, including the risk of arterial and venous thromboembolic disorders (blood clots). The label also notes an increased risk of probable dementia in older postmenopausal women when used in combination with estrogen.

Q: What is the official safety classification for Naturogest in pregnancy?

A: The official safety classification varies by regulatory body and indication. For the oral capsule form, the US FDA has assigned a pregnancy category B. For use in Assisted Reproductive Technology (ART), some regulatory bodies have assigned the medicine to Category A.

Q: Is it possible to take Naturogest for too long?

A: Official warnings exist that state that, in older postmenopausal women, extended combined use with estrogen was found to be associated with an increased risk of probable dementia.

Q: What are the main research themes being explored for Naturogest use?

A: Beyond its reproductive role, current research is exploring the drug's use related to its neurochemical effects in the brain. These research themes include the potential for alleviating symptoms of anxiety and depression and treatment of certain sleep disorders.

Q: Is it safe to drink alcohol in moderation while using Naturogest?

A: Regulatory warnings indicate that consuming alcohol while using this medication can increase the risk of side effects. These effects include potential increases in dizziness or fainting spells.

Q: Can Naturogest affect cholesterol levels according to medical literature?

A: Medical literature suggests that micronized progesterone may have a neutral or beneficial impact on lipid profiles (cholesterol levels). This is often noted when comparing its effects to those of certain synthetic progestins.

How should Naturogest be stored and disposed of?

How to Store and Dispose of Naturogest (Progesterone)

Official regulatory guidelines define strict conditions for the storage and disposal of progesterone (Naturogest) to maintain its stability and ensure safety.


Storage Requirements

The medication must be stored at controlled room temperature (CRT), specifically 20 to 25 C (68 to 77 F), with excursions permitted up to 30 C. It is crucial not to refrigerate or freeze the product. To protect the contents from light and moisture, the product must be kept in its original carton. For child safety, the medication must always be stored out of the reach and sight of children.


Disposal Instructions

Do not use the product past the expiration date on the carton. Unused or expired medication should not be flushed down the toilet or disposed of in wastewater. The preferred method is using a community drug take-back program. If this is unavailable, the product should be mixed with an undesirable substance, sealed in a container, and placed in the household trash, following FDA recommendations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Naturogest found in:

A-Z Index: